Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
Buzdar, A.U., Xu, B., Digumarti, R., Goedhals, L., Hu, X., Semiglazov, V., Cheporov, S., Gotovkin, E., Hoersch, S., Rittweger, K., Miles, D.W., O’Shaughnessy, J., Tjulandin, S.
Published in Annals of oncology (01.03.2012)
Published in Annals of oncology (01.03.2012)
Get full text
Journal Article
O001/#331 Empower-cervical 1/GOG-3016/ENGOT-CX9: results of phase 3 trial of cemiplimab vs investigator’s choice chemotherapy in recurrent/metastatic cervical carcinoma
Tewari, K, Monk, B, Vergote, I, Miller, A, De Melo, AC, Kim, HS, Kim, YM, Lisyanskaya, A, Samouelian, V, Lorusso, D, Damian, F, Chang, C-L, Gotovkin, EA, Takahashi, S, Ramone, D, Pikiel, J, Li, J, Mathias, M, Fury, MG, Oaknin, A
Published in International journal of gynecological cancer (01.11.2021)
Published in International journal of gynecological cancer (01.11.2021)
Get full text
Journal Article
Survival with Cemiplimab in Recurrent Cervical Cancer
Tewari, Krishnansu S, Monk, Bradley J, Vergote, Ignace, Miller, Austin, de Melo, Andreia C, Kim, Hee-Seung, Kim, Yong Man, Lisyanskaya, Alla, Samouëlian, Vanessa, Lorusso, Domenica, Damian, Fernanda, Chang, Chih-Long, Gotovkin, Evgeniy A, Takahashi, Shunji, Ramone, Daniella, Pikiel, Joanna, Maćkowiak-Matejczyk, Beata, Guerra Alía, Eva M, Colombo, Nicoletta, Makarova, Yulia, Rischin, Danny, Lheureux, Stephanie, Hasegawa, Kosei, Fujiwara, Keiichi, Li, Jingjin, Jamil, Shaheda, Jankovic, Vladimir, Chen, Chieh-I, Seebach, Frank, Weinreich, David M, Yancopoulos, George D, Lowy, Israel, Mathias, Melissa, Fury, Matthew G, Oaknin, Ana
Published in The New England journal of medicine (10.02.2022)
Published in The New England journal of medicine (10.02.2022)
Get full text
Journal Article
VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma
Tewari, K.S., Monk, B.J., Vergote, I., Miller, A., de Melo, A.C., Kim, H.S., Kim, Y.M., Lisyanskaya, A., Samouëlian, V., Lorusso, D., Damian, F., Chang, C-L., Gotovkin, E.A., Takahashi, S., Ramone, D., Pikiel, J., Li, J., Mathias, M., Fury, M.G., Oaknin, A.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
1514P Randomized, global, phase III study of tislelizumab (TIS) + chemotherapy (chemo) vs placebo (PBO) + chemo as first-line (1L) treatment for advanced/metastatic esophageal squamous cell carcinoma (ESCC): RATIONALE-306 update
Hubner, R., Xu, J., Kato, K., Raymond, E., Shu, Y., Pan, Y., Jiang, Y., Zhang, J., Park, S.R., Kojima, T., Lin, C-Y., Gotovkin, E., Wyrwicz, L.S., Ishihara, R., Wu, H., Peng, Y., Wang, L., Li, L., Yoon, H.H.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA-1 RATIONALE-306: Randomized, global, placebo-controlled, double-blind phase 3 study of tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC)
Yoon, H., Kato, K., Raymond, E., Hubner, R., Shu, Y., Pan, Y., Jiang, Y., Zhang, J., Park, S., Kojima, T., Lin, C., Gotovkin, E., Wyrwicz, L., Ishihara, R., Li, L., Tao, A., Shi, J., Wang, L., Xu, J.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
Final results of the FAST study, an international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma
Schuler, M., Al-Batran, S.-E., Zvirbule, Z., Manikhas, G., Lordick, F., Rusyn, A., Vinnyk, Y., Vynnychenko, I., Fadeeva, N., Nechaeva, M., Dudov, A., Gotovkin, E., Pecheniy, A., Bazin, I., Bondarenko, I., Melichar, B., Huber, C., Türeci, Ö, Sahin, U.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
220O Claudin 18.2 - a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer
Lordick, F., Schuler, M., Al-Batran, S.-E., Zvirbule, Z., Manikhas, G., Rusyn, A., Vinnyk, Y., Vynnychenko, I., Fadeeva, N., Nechaeva, M., Dudov, A., Gotovkin, E., Pecheniy, A., Bazin, I., Bondarenko, I., Melichar, B., Huber, C., Sahin, U., Tu¨ reci, O.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
220O Claudin 18.2 – a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer
Lordick, F., Schuler, M., Al-Batran, S-E., Zvirbule, Z., Manikhas, G., Rusyn, A., Vinnyk, Y., Vynnychenko, I., Fadeeva, N., Nechaeva, M., Dudov, A., Gotovkin, E., Pecheniy, A., Bazin, I., Bondarenko, I., Melichar, B., Huber, C., Sahin, U., Türeci, Ö.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
(Q)-TWiST analysis of trastuzumab plus fluoropyrimidine/cisplatin (T-XP/FP) versus XP/FP alone as first-line therapy for advanced HER2-positive gastric cancer
Chung, H. C., Bang, Y., Van Cutsem, E., Kang, Y., Hamamoto, Y., Moiseyenko, V., Gotovkin, E., Urspruch, A., Ducournau, P.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Abstract P6-11-02: Final Analysis of NO16853, a Randomized Phase II Non-Inferiority Study of Two Different Doses of Capecitabine in Combination with Docetaxel for Locally Advanced/Metastatic Breast Cancer (LA/MBC)
Buzdar, A, Tjulandin, S, Xu, B, Digumarti, R, Goedhals, L, Hu, X, Semiglazov, V, Cheporov, S, Gotovkin, E, Gilberg, F, Rittweger, K, Schaedeli Stark, F.
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Get full text
Journal Article
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
Buzdar, A U, Xu, B, Digumarti, R, Goedhals, L, Hu, X, Semiglazov, V, Cheporov, S, Gotovkin, E, Hoersch, S, Rittweger, K, Miles, D W, O'Shaughnessy, J, Tjulandin, S
Published in Annals of oncology (01.03.2012)
Get full text
Published in Annals of oncology (01.03.2012)
Journal Article
Izuchenie gemtsitabina (Gemzar®)i tsisplatina v pervoy linii terapiirasprostranennogo raka yaichnika(issledovanie II fazy)
V A Gorbunova, N V Kovalenko, E V Shevyakova, E A Gotovkin, A S Lisyanskaya, V V Dvornichenko, M Yu Byakhov, I N Petukhova
Published in Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia (01.09.2010)
Get full text
Published in Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia (01.09.2010)
Journal Article
DUST-RIDDEN AIR INVESTIGATING DEVICE
KLIMENKO ALBINA P,SU, MIKHALEVICH SERGEJ N,SU, DEMIDOV LEONID A,SU, GOTOVKIN VIKTOR E,SU, DUNSKIJ STANISLAV A,SU, DASHEVSKIJ LEV N,SU
Year of Publication 18.07.1979
Get full text
Year of Publication 18.07.1979
Patent